Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:23-29

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imanishi, M.
Right arrow Articles by Takamiya, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imanishi, M.
Right arrow Articles by Takamiya, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
Related Collections
Right arrow Other hypertension
Right arrow Clinical Studies

(Hypertension. 2001;38:23.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Prostaglandin I2/E2 Ratios in Unilateral Renovascular Hypertension of Different Severities

Masahito Imanishi; Tetsu Tsuji; Satoko Nakamura; Makoto Takamiya

From the Department of Medicine, Osaka City General Hospital (M.I.), and the National Cardiovascular Center, Suita (T.T., S.N., M.T.), Osaka, Japan.

Correspondence to Masahito Imanishi, MD, Department of Medicine, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka 534-0021, Japan. E-mail masachan{at}msic.med.osaka-cu.ac.jp

Abstract— Differences between prostaglandins I2 and E2 in their renal synthesis and pathophysiological roles were investigated in unilateral renovascular hypertension of different severities in 18 patients: 6 with mild stenosis (<75% of the diameter) of the renal artery, 7 with moderate stenosis (75% to 90%), and 5 with severe stenosis (>90%). Before and after aspirin administration (10 mg/kg), renal venous and aortic plasma was assayed for 6-ketoprostaglandin F1{alpha} (instead of prostaglandin I2), prostaglandin E2, and renin activity. In mild or moderate stenosis, the mean 6-ketoprostaglandin F1{alpha} level in renal venous plasma from the stenotic side was not different from that from the normal side or from aortic plasma. Prostaglandin E2 levels and renin activity in such patients were higher on the stenotic side than on the normal side and higher in venous than in aortic plasma. Aspirin inhibited prostaglandin E2 synthesis and suppressed renin release from stenotic kidneys and lowered blood pressure as the renin activity decreased in patients with mild or moderate stenosis. In severe stenosis, levels of 6-ketoprostaglandin F1{alpha} and prostaglandin E2 were higher on the stenotic side than on the normal side and higher in venous than in aortic plasma. Aspirin inhibited the synthesis of both prostaglandins and suppressed renin release from the stenotic kidney. In patients with unilateral renovascular hypertension with mild or moderate stenosis of the renal artery, prostaglandin E2, rather than I2, seems to contribute to further acceleration of renin release. Prostaglandin I2 may increase and participate in further renin release when the stenosis is severe.


Key Words: prostaglandins • hypertension, renovascular • kidney




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Theilig, H. Debiec, B. Nafz, P. Ronco, R. Nusing, H. W. Seyberth, H. Pavenstadt, N. Bouby, and S. Bachmann
Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat)
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F987 - F994.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. L. Therland, J. Stubbe, H. C. Thiesson, P. D. Ottosen, S. Walter, G. L. Sorensen, O. Skott, and B. L. Jensen
Cycloxygenase-2 Is Expressed in Vasculature of Normal and Ischemic Adult Human Kidney and Is Colocalized with Vascular Prostaglandin E2 EP4 Receptors
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1189 - 1198.
[Abstract] [Full Text] [PDF]